Grazia Equity GmbH — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

ZAGENOzageno.comMay 2023 · $33M

ZAGENO operates a lab supply procurement platform that lets pharma, biotech, and life sciences teams search, compare, and order over 50M SKUs from more than 6,000 suppliers through a single system.

B2B MarketplacesBiotechSaaSCambridge, US

Florian Wegener(Executive Officer, Director, Promoter)inDavid Pumberger(Executive Officer, Director, Promoter)inKilian Veer(Executive Officer, Director, Promoter)

BoardAlec Rauschenbusch(Director)inLarry Bohn(Director)inJosef Von Rickenbach(Director)

Co-investorsCaesar Business Angels Caesar Ventures Capnamic FJ Labs General Catalyst Nat Turner +1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.